Abstract:IMPORTANCE: The dream enactment of rapid eye movement sleep behavior disorder (RBD) is often the first indication of an impending α-synuclein disorder, such as Parkinson disease, multiple-system atrophy, or dementia with Lewy bodies.OBJECTIVE: To provide an overview of RBD from the onset of dream enactment through the emergence of a parkinsonian disorder.EVIDENCE REVIEW: Peer-reviewed articles, including case reports, case series, retrospective reviews, prospective randomized trials, and basic science investigations, were identified in a PubMed search of articles on RBD from January 1, 1986, through July 31, 2014.FINDINGS: Under normal conditions, vivid dream mentation combined with skeletal muscle paralysis characterizes rapid eye movement sleep. In RBD, α-synuclein abnormalities in the brainstem disinhibit rapid eye movement sleep motor activity, leading to dream enactment. The behaviors of RBD are often theatrical, with complexity, aggression, and violence; fighting and fleeing actions can be injurious to patients as well as bed partners. Rapid eye movement sleep behavior disorder is distinguished from other parasomnias by clinical features and the demonstration of rapid eye movement sleep without atonia on polysomnography. Consistent with early neurodegeneration, patients with RBD demonstrate subtle motor, cognitive, and autonomic impairments. Approximately 50% of patients with spontaneous RBD will convert to a parkinsonian disorder within a decade. Ultimately, nearly all (81%-90%) patients with RBD develop a neurodegenerative disorder. Among patients with Parkinson disease, RBD predicts a non-tremor-predominant subtype, gait freezing, and an aggressive clinical course. The most commonly cited RBD treatments include low-dose clonazepam or high-dose melatonin taken orally at bedtime.CONCLUSIONS AND RELEVANCE: Treatment of RBD can prevent injury to patients and bed partners. Because RBD is a prodromal syndrome of Parkinson disease (or related disorder), it represents a unique opportunity for developing and testing disease-modifying therapies.

Retinal Nerve Fiber Layer Thinning: a Window into Rapid Eye Movement Sleep Behavior Disorders in Parkinson’s Disease

Abnormal Eye Movements in Patients with Idiopathic Rapid Eye Movement Sleep Behavior Disorder

Alterations of Brain Structural Network in Parkinson’s Disease with and Without Rapid Eye Movement Sleep Behavior Disorder

Wider and Faster Degeneration of White Matter in Parkinson’s Disease with Possible REM Sleep Behaviour Disorder

Impaired Ocular Tracking and Cortical Atrophy in Idiopathic Rapid Eye Movement Sleep Behavior Disorder

Abnormal Baseline Brain Activity in Parkinson's Disease with and Without REM Sleep Behavior Disorder: A Resting‐state Functional MRI Study

Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Diseases: An Update

Altered Nigrostriatal and Nigrocortical Functional Connectivity in Rapid Eye Movement Sleep Behavior Disorder

Different Patterns of Exosomal Α‐synuclein Between Parkinson's Disease and Probable Rapid Eye Movement Sleep Behavior Disorder

Longitudinal Network Changes and Phenoconversion Risk in Isolated REM Sleep Behavior Disorder

Alterations of Peripheral Lymphocyte Subsets in Isolated Rapid Eye Movement Sleep Behavior Disorder

REM Sleep Behaviour Disorder: Prodromal and Mechanistic Insights for Parkinson's Disease

Functional Neuroimaging in Idiopathic Rapid Eye Movement Sleep Behavior Disorder

A retrospective study on rapid eye movement sleep behavior disorder in Parkinson's disease

Rapid Eye Movement Sleep Behavior Disorder As a Predicting Phenomenon of Α-Synucleinopathies( Report of 1 Case)

Clinical Features of Parkinson’s Disease with and Without Rapid Eye Movement Sleep Behavior Disorder

Neuroanatomical findings in isolated REM sleep behavior disorder and early Parkinson's disease: a Voxel-based morphometry study

From Rapid Eye Movement Sleep Behavior Disorder to Parkinson’s Disease: Possible Predictive Markers of Conversion

Considering REM Sleep Behavior Disorder in the Management of Parkinson’s Disease

Cortical Hypoperfusion in Patients with Idiopathic Rapid Eye Movement Sleep Behavior Disorder Detected with Arterial Spin-Labeled Perfusion MRI.

Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Disease